Vertex Pharmaceuticals (NASDAQ: VRTX) has been a big disappointment for investors in 2021. While the S&P 500 index soared nearly 30%, Vertex's shares are down 5%. Here are both bull and bear arguments for the biotech stock. Read More...
Motley Fool
Why Pfizer, BioNTech, and Moderna Shot Higher Today
Three of the top coronavirus stocks, Pfizer (NYSE: PFE), BioNTech (NASDAQ: BNTX), and Moderna (NASDAQ: MRNA), saw plenty of action on the market Thursday. Encouraging news for Pfizer and BioNTech’s Comirnaty coronavirus vaccine pushed the share prices of those two companies slightly higher on the day, by a respective 1.4% and 6.7%, with fellow jab maker Moderna cruising along for the ride with a 1.5% gain. A report published Thursday morning in The New York Times stated that the Food and Drug Administration (FDA) plans to authorize booster shots of Pfizer and BioNTech’s vaccine for people aged 12 to 15.
Add Comment